World Journal of
Pharmaceutical and Life Sciences

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical and Life Sciences
An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)
World Journal of Pharmaceutical and Life Sciences (WJPLS) has indexed with various reputed international bodies like : Google Scholar, Index Copernicus, Scientific Indexing Services (SIS), Indian citation Index (ICI), Directory of Research Journals Indexing, Scintific journal impact factorScientific Journal Impact Factor (SJIF), Jour Informatics (Under Process), UDLedge Science Citation Index, Global Impact Factor (In Process), International Impact Factor Services, International Society for Research Activity (ISRA) Journal Impact Factor (JIF), Science Library Index, Dubai, United Arab Emirates, International Innovative Journal Impact Factor (IIJIF), Scientific Journal Impact Factor (SJIF), Eurasian Scientific Journal Index (ESJI), Cosmos Impact Factor, IFSIJ Measure of Journal Quality, International Scientific Indexing, UAE (ISI), Web of Science Group (Under Process), Research Bible, Fuchu, Tokyo. JAPAN, Scholar Article Journal Index (SAJI), Scope Database, Academia, 



Cornelius Nwozor*, Peter Ughachukwu, Henry Enwelum, Kosisochukwu Ifemenam, Chiemelia Anisiobi, Evarista Chiamaka Chima-iwuoha


Diabetes mellitus (DM) is a chronic metabolic disorder characterized by hyperglycemia. In 2010 about 285 million people worldwide had DM. By 2030 438 million adults will have DM. In Nigeria, about 4 million people are living with DM. There are two types of DM: type 1 and 2. Type 2 DM is the commonest DM in an adult population. Treatment is based on the use of oral hypoglycemic drugs when diet fails. Pharmacoeconomics refers to the scientific discipline that compares the value of one pharmaceutical drug or drug therapy to another. This branch of healthcare economics offers important guidance for the management of limited healthcare resources and medical practice. Cost of drug is the total resources consumed in producing the drug or drug formulation. Cost can be divided into: direct, indirect, and intangible cost. Types of pharmacoeconomic evaluation include: cost effectiveness analysis (CEA), cost minimization analysis (CMA), cost benefit analysis (CBA), cost utility analysis (CUA). Pharmacoeconomic evaluation showed that biguanide had the lowest cost per unit. However, sulfonylureas provided superior incremental cost-effectiveness ratio (ICER).

[Full Text Article]   [Download Certificate]


  All Since 2019
 Citation  422  322
 h-index  9  7
 i10-index  4  2



    A PHP Error was encountered

    Severity: Notice

    Message: Undefined variable: news

    Filename: views/right_panel.php

    Line Number: 79

    A PHP Error was encountered

    Severity: Warning

    Message: Invalid argument supplied for foreach()

    Filename: views/right_panel.php

    Line Number: 79


World Journal of Pharmaceutical and life sciences Will give best paper award in every issue in the from of money along with certificate to promote research .

Best Article of current issue

Download Article : Click here